Masoud Khayyami, Chairperson
Born 1963. Doctor of Biochemistry at Lund University.
Education and background: Solid experience from research, medicine, medtech and biotechnology sectors. Extensive entrepreneurial experience (Pro-light Diagnostics AB, SpectraCure AB) and expert knowledge in applied medicine, microbiology and biotech, especially in the development of different types of biomolecules for commercial use and research in biological applications. Member of the board of both medtech companies and other companies.
Total shares as well as related parties and companies: 8,699,945 (4,000,000 which are shares via Cardeon AB, 40 percent ownership).
Dependent in relation to the Company's major shareholders, but independent in relation to the Company and company management.